intermediate risk prostate cancer

Showing 1 - 7 of 7

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Localized Prostate Cancer, Low Risk Prostate Cancer, Intermediate Risk Prostate Cancer Trial (3 fractions of prostate SBRT)

Not yet recruiting
  • Localized Prostate Cancer
  • +2 more
  • 3 fractions of prostate SBRT
  • (no location specified)
Oct 31, 2023

Localized Prostate Carcinoma, Castration-Naive Prostate Cancer, Intermediate Risk Prostate Cancer Trial in Turku (Degarelix,

Not yet recruiting
  • Localized Prostate Carcinoma
  • +3 more
  • Degarelix
  • MRI-guided transurethral ultrasound ablation (TULSA)
  • Turku, Southwest Finland, Finland
    Turku University Hospital
Jun 14, 2023

Intermediate Risk Prostate Cancer Trial in Boston (Enzalutamide, External Beam Radiation)

Active, not recruiting
  • Intermediate Risk Prostate Cancer
  • Boston, Massachusetts
  • +2 more
Jul 26, 2021

Low Risk Prostate Cancer, Intermediate Risk Prostate Cancer Trial in Wiener Neustadt (EPIC questionnaire, kV x-ray images,

Recruiting
  • Low Risk Prostate Cancer
  • Intermediate Risk Prostate Cancer
  • EPIC questionnaire
  • +2 more
  • Wiener Neustadt, Niederösterreich, Austria
    EBG MedAustron GmbH
May 3, 2021

Intermediate Risk Prostate Cancer, Castration-resistant Prostate Cancer Trial in Manchester, Oxford (ChAdOx1-MVA 5T4 vaccine,

Unknown status
  • Intermediate Risk Prostate Cancer
  • Castration-resistant Prostate Cancer
  • ChAdOx1-MVA 5T4 vaccine
  • Nivolumab Infusion [Opdivo]
  • Manchester, United Kingdom
  • +1 more
Nov 27, 2020

Intermediate Risk Prostate Cancer, High Risk Prostate Cancer Trial in Brescia

Active, not recruiting
  • Intermediate Risk Prostate Cancer
  • High Risk Prostate Cancer
    • Brescia, Italy
      University and Spedali Civili - Brescia
    Mar 16, 2020

    Assessment of New Radiation Oncology Technologies and Treatments

    Completed
    • Prostate Cancer (Post Prostatectomy)
    • +3 more
    • Non-Interventional Study
    • Camperdown, New South Wales, Australia
    • +14 more
    Feb 12, 2013